Changes in relative fatty acid composition of serum lecithin and cholesterol ester after treatment with two gonane progestins administered alone and in combination with ethinyl estradiol
- PMID: 6239594
- DOI: 10.1007/BF02114866
Changes in relative fatty acid composition of serum lecithin and cholesterol ester after treatment with two gonane progestins administered alone and in combination with ethinyl estradiol
Abstract
Twenty women, oophorectomized as part of treatment for cervical carcinoma of the cervix participated in the study. Ten of them were given desogestrel (DG) 150 micrograms/day for 3 weeks followed by DG + 30 micrograms ethinyl estradiol (EE) for 6 weeks, and finally EE alone for 3 weeks. The other 10 women were given 150 micrograms levonorgestrel (NORG) and EE in a similar way. Before treatment and after each period of treatment the relative fatty acid composition of serum lecithin and serum cholesterol ester were assessed by gas-liquid chromatography. In both groups ethinyl estradiol, when administered alone, increased arachidonic acid in serum lecithin. This increase was not observed on the DG + EE or the NORG + EE combination indicating that both progestins counteracted this estrogenic effect.
Similar articles
-
Changes in serum apo-lipoprotein AI and sex-hormone-binding globulin levels after treatment with two different progestins administered alone and in combination with ethinyl estradiol.Contraception. 1984 Mar;29(3):261-70. doi: 10.1016/s0010-7824(84)80006-2. Contraception. 1984. PMID: 6234148
-
The effects of two gonane progestins alone and in combination with ethinyl estradiol on serum lipoproteins.Eur J Obstet Gynecol Reprod Biol. 1985 Jun;19(6):365-74. doi: 10.1016/0028-2243(85)90134-0. Eur J Obstet Gynecol Reprod Biol. 1985. PMID: 3160616
-
Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.J Clin Endocrinol Metab. 1987 Dec;65(6):1238-42. doi: 10.1210/jcem-65-6-1238. J Clin Endocrinol Metab. 1987. PMID: 2960690
-
Clinical aspects of three new progestogens: desogestrel, gestodene, and norgestimate.Am J Obstet Gynecol. 1989 May;160(5 Pt 2):1296-300. doi: 10.1016/s0002-9378(89)80016-x. Am J Obstet Gynecol. 1989. PMID: 2524163 Review.
-
Desogestrel, norgestimate, and gestodene: the newer progestins.Ann Pharmacother. 1995 Jul-Aug;29(7-8):736-42. doi: 10.1177/106002809502907-817. Ann Pharmacother. 1995. PMID: 8520092 Review.